The estimated Net Worth of Andrea Lynn Saia is at least $8.64 Million dollars as of 17 May 2024. Ms. Saia owns over 1,029 units of Align Technology stock worth over $3,247,789 and over the last 11 years she sold ALGN stock worth over $5,005,786. In addition, she makes $381,979 as Independent Director at Align Technology.
Andrea has made over 26 trades of the Align Technology stock since 2014, according to the Form 4 filled with the SEC. Most recently she exercised 1,029 units of ALGN stock worth $231,679 on 17 May 2024.
The largest trade she's ever made was exercising 5,500 units of Align Technology stock on 13 May 2016 worth over $1,238,325. On average, Andrea trades about 1,507 units every 79 days since 2013. As of 17 May 2024 she still owns at least 14,425 units of Align Technology stock.
You can see the complete history of Ms. Saia stock trades at the bottom of the page.
Andrea L. Saia is Independent Director of the Company. She has served as a director of Align since July 2013. She was previously the Global Head of Vision Care in the Alcon division of Novartis AG, from 2011 until her retirement in 2012. Prior to this role, she served as President and Chief Executive Officer of CibaVision Corporation, a subsidiary of Novartis, from 2008 to 2011. From 2005 to 2007, she relocated to Switzerland and served as President of Europe, Middle East, and Africa operations, CibaVision’s largest regional business unit. She initially joined CibaVision in 2002 as Global Head of Marketing and was promoted to President of the Global Lens Business the following year. Prior to Novartis, Ms. Saia was the Chief Marketing Officer for GCG Partners Inc. Ms. Saia also held senior management and marketing positions with global consumer products companies such as Procter & Gamble Co., Unilever, and Revlon, Inc. Ms. Saia earned an M.B.A. from J.L. Kellogg Graduate School of Management and a B.S. in Business Administration from Miami University. Since July 2016, Ms. Saia has served on the board of directors of LivaNova PLC, a global medical technology company and currently serves on the board of the Farmer School of Business at Miami University. Previously, Ms. Saia served on the board of directors of Coca-Cola Enterprises, Inc., the marketer, producer and distributor of Coca-Cola products in European markets from 2012 to 2016.
As the Independent Director of Align Technology, the total compensation of Andrea Saia at Align Technology is $381,979. There are 12 executives at Align Technology getting paid more, with Joseph Hogan having the highest compensation of $18,269,100.
Andrea Saia is 62, she's been the Independent Director of Align Technology since 2013. There are 5 older and 24 younger executives at Align Technology. The oldest executive at Align Technology, Inc. is Charles Larkin, 71, who is the Independent Chairman of the Board.
Andrea's mailing address filed with the SEC is 3052 ORCHARD DRIVE, , SAN JOSE, CA, 95134.
Over the last 22 years, insiders at Align Technology have traded over $1,465,859,191 worth of Align Technology stock and bought 2,715,224 units worth $38,925,222 . The most active insiders traders include Brian H Dovey, Kevin T Conroy, and Corp /De/ Danaher. On average, Align Technology executives and independent directors trade stock every 11 days with the average trade being worth of $6,502,557. The most recent stock trade was executed by C Raymond Jr Larkin on 15 August 2024, trading 6,500 units of ALGN stock currently worth $1,529,645.
align technology is a global medical device company with industry-leading innovative products -- invisalign clear aligners and itero intraoral scanners -- that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. invisalign system invisalign clear aligners have been used to straighten teeth and treat minor to complex malocclusion for more than 3 million patients worldwide. the invisalign system is a combination of proprietary virtual modeling software and rapid mass-manufacturing processes used to develop a treatment plan and with custom-made aligners for each patient. invisalign is prescribed to patients through invisalign-trained orthodontists and general practitioner dentists (gp) and is offered in over 90 countries. learn more at www.invisalign.com itero intraoral scanner the itero scanner’s parallel confocal imaging technology uses optical and laser scanning to achieve a high level of precisi
Align Technology executives and other stock owners filed with the SEC include: